Camlin Fine Sciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

15.71

15.70

12.75

12.13

12.13

Share application money

14.31

12.20

4.69

0.44

22.39

Preference share capital

-

-

-

-

-

Reserves & surplus

608.82

561.14

443.88

360.92

309.60

Loan funds

Secured loans

607.65

450.97

376.25

334.69

313.42

Unsecured loans

-

-

-

-

-

Total

1,246.48

1,040.00

837.58

708.18

657.53

Uses of funds

Fixed assets

Gross block

675.78

376.03

342.04

128.89

107.48

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

92.73

71.76

48.31

33.25

25.81

Net block

583.05

304.27

293.73

95.64

81.67

Capital work-in-progress

28.36

206.87

18.44

198.20

68.48

Investments

81.80

81.78

73.56

74.02

68.97

Net current assets

Current assets, loans & advances

900.61

753.02

680.98

523.49

561.64

Less : current liabilities & provisions

347.33

305.93

229.14

183.16

123.23

Total net current assets

553.28

447.09

451.84

340.32

438.41

Miscellaneous expenses not written

-

-

-

-

-

Total

1,246.48

1,040.00

837.58

708.18

657.53

Notes:

Book value of unquoted investments

81.80

81.78

73.56

74.02

68.97

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

135.07

138.98

125.63

257.70

287.94

Number of equity sharesoutstanding (Lacs)

1570.93

1569.84

1274.98

1212.54

1212.54